Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?

Gastroenterology. 2017 May;152(6):1624-1625. doi: 10.1053/j.gastro.2017.01.061. Epub 2017 Mar 31.

Authors

Etienne Garin¹, Xavier Pallard¹, Julien Edeline²

Affiliations

¹ Cancer Institute Eugène Marquis, Department of Nuclear Medicine and University of Rennes 1 and INSERM, U-991, Liver Metabolisms and Cancer, Rennes, France.
² Cancer Institute Eugène Marquis, Department of Medical Oncology and University of Rennes 1 and Insern U991, Rennes, France.

PMID: 28371622
DOI: 10.1053/j.gastro.2017.01.061

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic
Embolization, Therapeutic
Humans
Liver Neoplasms*
Treatment Outcome
Yttrium Radioisotopes

Substances

Yttrium Radioisotopes